RILMENIDINE HEMIFUMARATE SALT
中文名称 | RILMENIDINE HEMIFUMARATE SALT |
---|---|
中文同义词 | 化合物 T21911;利美尼定半富马酸盐;利美尼啶半富马酸盐 |
英文名称 | RILMENIDINE HEMIFUMARATE SALT |
英文同义词 | RILMENIDINE HEMIFUMARATE SALT;n-(dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt;Oxaminozoline hemifumarate salt, Rilmenidene hemifumarate salt, N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine hemifumarate salt;LZFATBMLSYHRTC-WXXKFALUSA-N |
CAS号 | 207572-68-7 |
分子式 | 2C10H16N2O.C4H4O4 |
分子量 | 476.57 |
EINECS号 | |
相关类别 | |
Mol文件 | 207572-68-7.mol |
结构式 | ![]() |
RILMENIDINE HEMIFUMARATE SALT 性质
储存条件 | Store at -20°C |
---|---|
溶解度 | 二甲基亚砜:>10mg/mL |
形态 | 固体 |
颜色 | 白色 |
Rilmenidine provides antihypertensive efficacy comparable with that of diuretics, beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors.
Rilmenidine (25-100 μM; 24 hours) inhibits K562 cell proliferation.
Cell Viability Assay
Cell Line: | K562 cells |
Concentration: | 25, 50, 100 μM |
Incubation Time: | 24 hours |
Result: | Dose-dependently inhibited K562 colony formation. |
Rilmenidine-treated N171-82Q mice (i.p.; 4-times a week) displays significant improved forelimb grip strength and all limbs grip strength from 12 to 22 weeks of age.
Rilmenidine decreases levels of mutant huntingtin.
安全信息
安全说明 | 22-24/25 |
---|---|
WGK Germany | 3 |
RTECS号 | RP7207400 |